Integrated DNA Technologies acquires oligonucleotide synthesis company ValueGene

Adds new customers with promise to provide seamless support for genomics research

ValueGene's Longze Cui (left) and General Manager of IDT West Coast Operations, Dan Dernbach (right), at the closing of the acquisition

Integrated DNA Technologies (IDT), a specialist in customised nucleic acid synthesis, has acquired ValueGene, an oligonucleotide synthesis services company based in San Diego, CA, US, for an undisclosed sum.

ValueGene offers customised DNA and RNA oligonucleotide synthesis products, including PAGE and HPLC purification and modification services.

Dr Joseph Walder, IDT Founder and Chief Executive, said: 'We look forward to maximising the synergies between our two companies and building on ValueGene’s long history of providing quality products and services to its customers.'